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Abstract 
Introduction: Adipose tissue (AT) has become a source of mesenchymal stromal/stem cells (MSC) for regenera-
tive medicine applications, in particular skeletal disorders. Several enzymatic or mechanical procedures have been 
proposed to process AT with the aim to isolate cells that can be locally implanted. How AT is processed may impact 
its properties. Thus, we compared AT processed by centrifugation (C-AT) to microfragmentation (MF-AT). Focusing on 
MF-AT, we subsequently assessed the impact of synovial fluid (SF) alone on both MF-AT and isolated AT-MSC to better 
understand their cartilage repair mechanisms.
Materials and methods: MF-AT and C-AT from the same donors were compared by histology and qRT-PCR imme-
diately after isolation or as ex vivo cultures using a micro-tissue pellet system. The in vitro impact of SF on MF-AT and 
AT-MSC was assessed by histological staining and molecular analysis.
Results: The main AT histological features (i.e., increased extracellular matrix and cellularity) of the freshly isolated or 
ex vivo-cultured MF-AT persisted compared to C-AT, which rapidly deteriorated during culture. Based on our previous 
studies of HOX genes in MSC, we investigated the involvement of Homeobox Protein HOX-B7 (HOXB7) and its target 
basic Fibroblast Growth Factor (bFGF) in the molecular mechanism underlying the improved performance of MF-AT. 
Indeed, both these biomarkers were more prominent in freshly isolated MF-AT compared to C-AT. SF alone preserved 
the AT histological features of MF-AT, together with HOXB7 and bFGF expression. Increased cell performance was also 
observed in isolated AT-MSC after SF treatment concomitant with enhanced HOXB7 expression, although there was 
no apparent association with bFGF.
Conclusions: Our findings show that MF has a positive effect on the maintenance of AT histology and may trigger 
the expression of trophic factors that improve tissue repair by processed AT.
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Introduction
Adipose tissue (AT) is a connective tissue composed of 
different cell types (e.g., adipocytes, pre-adipocytes and 
endothelial, hematopoietic, and stromal cells). Its main 
functions are mechanical protection, storage and release 
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of energy, regulation of homeostasis and the secretion of 
adipokines [1–3]. Because of its availability as a biocom-
patible filler and its integration capacity into implantation 
sites, AT has been increasingly used in clinical proce-
dures in autologous settings [4, 5]. Autologous grafted AT 
promotes tissue regeneration due to the presence of adi-
pose tissue-derived mesenchymal stromal or stem cells 
(AT-MSC) within the so-called stromal vascular fraction 
(SVF) [6]. Several evidences report a significant positive 
clinical outcome such us in plastic surgery in the treat-
ment of ulcers, burns, scars, soft tissue augmentation [5, 
7–9]. The application of AT-MSC was not confined to 
plastic surgery but was also extended to cardiac, rheuma-
toid, gastro-intestinal and musco-skeletal fields, etc [10–
12]. For this reason, different enzymatic and mechanical 
procedures have been established for processing AT to 
isolate cells that can be locally implanted [13, 14].
The standard harvesting procedure has been the Cole-
man technique, which uses liposuction followed by a cen-
trifugation separation step to recover adipocytes and SVF 
for re-engraftment into the patient [4]. Although centri-
fuged AT (C-AT) has applications in the field of plastic 
and reconstructive surgery, pre-clinical and clinical stud-
ies have identified some limitations to this method, such 
as the appearance of fibrotic tissue after transplantation 
and partial graft reabsorption [15, 16]. Because how AT 
is processed may impact its properties, innovative sys-
tems of AT harvesting and processing have been devel-
oped [17]. New non-enzymatic methods can obtain a fat 
tissue derivative highly enriched in pericyte-like elements 
by mild mechanical forces from human lipoaspirates 
[14]. Among these methods, the microfragmentation 
AT (MF-AT) procedure can provide minimally manipu-
lated ready-to-use AT-derived product by mechanical 
forces in the absence of enzymatic digestion. This tech-
nology processes lipoaspirates from patients by progres-
sive size reduction of AT clusters through two filters and 
five stainless steel marbles [14]. The processed AT can be 
used in several tissue regeneration approaches, such as 
general surgery [8], plastic reconstructive and aesthetic 
surgery [18], oral-maxillofacial surgery and orthopaedic 
surgery for patients affected by osteoarthritis [19–21].
The rationale for using MF-AT in regenerative medi-
cine is that this process maintains viable pericytes and 
AT-MSC within a preserved stromal vascular niche [14]. 
In osteoarthritis, MF-AT technology generates autolo-
gous tissue that can then be engrafted into the joint of the 
patient during a one-step surgery. Preliminary data (Level 
IV studies, case series) showed a clinically relevant reduc-
tion in pain, improved knee function and increased artic-
ular cartilage thickness even after two years of follow-up 
[22–25]. However, the mechanisms underlying the ben-
eficial effects of MF-AT are not clearly understood [22, 
26]. It is unclear what occurs in knees of osteoarthritic 
patients after MF-AT intra-articular injection. The cells 
themselves may be incorporated into the damaged tissue 
and differentiate into chondrocytes, or MF-AT may acti-
vate reparative mechanisms through specific pathways 
that influence resident chondrocyte repair, inflammation 
or both processes. In our previous studies, we showed 
how genes belonging to the HOXB family are associ-
ated with adipose and bone marrow MSC performance 
(i.e., osteogenesis and chondrogenesis) in association 
with increased basic Fibroblast Growth Factor (bFGF) 
[27, 28]. In those studies, the role of Homeobox Protein 
HOX-B7 (HOXB7) as a regulator of skeleton homeosta-
sis was established, suggesting that HOXB7 can affect 
MSC through a bFGF-mediated autocrine loop [27]. It is 
known that bFGF promotes self-renewal and prolifera-
tion while inhibiting cellular senescence and ageing [29]. 
Tasso et al. [30] have demonstrated that AT-MSC stimu-
lated in  vitro by bFGF may secrete proteins involved in 
immune and inflammatory responses, wound healing 
and chemotaxis. When implanted in vivo, these cells can 
indirectly trigger wound healing and endogenous regen-
erative mechanisms following tissue damage [30].
Osteoarthritis (OA) is a pathological condition result-
ing in cartilage degradation and bone damage [31]. A 
close relationship between cytokine expression and OA 
has been found [32, 33].
In fact, it was shown that interleukin-1 (IL-1) and 
tumour necrosis factor-alpha (TNF-alpha) can induce 
the production of interleukin-6 (IL-6) and interleukin-8 
(IL-8) by synovial cells.
Synovial Fluid (SF) has biomechanical, metabolic, 
and regulatory functions. SF is normally a clear, straw-
colored, viscous liquid [34]. A major component of SF 
composition is proteins such as cytokines and growth 
factors that are at relatively low concentrations in normal 
SF, and are markedly elevated in joint injury and disease. 
Cytokines may be categorized as pro- or anti-inflam-
matory according to their predominant tissue-specific 
effects. For example, in SF cytokines such as IL-1α, IL-1β, 
TNF-α, leukemia inhibitory factor (LIF), IL-6, IL-8, IL-17, 
and IL-18 play a pro-inflammatory effect, whereas IL-4, 
IL-10, and IL-13 exert and anti-inflammatory potential. 
Growth factors found in SF include TGF-β1 and insulin 
growth factor 1 (IGF-I) and have anabolic effects. Most 
important are also several binding proteins in SF and 
playing an important role in cell regulation [35].
In the current study, we compared the in vitro fates of 
MF-AT and C-AT using a micro-tissue system with or 
without pathologic (i.e., osteoarthritic) SF to artificially 
mimic the articular space and the processes happening 
in  vivo after AT transplant. Histological and molecular 
analyses, including examination of changes in HOXB7 
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and bFGF expression, were used to investigate how the 
knee microenvironment can be positively influenced by 
processed AT (Fig. 1).
Results
Adipose tissue microfragmentation preserves the stromal 
fraction better than the Coleman technique
Freshly isolated C-AT and MF-AT obtained from the 
same donors (n = 10) were analysed for basic AT features. 
The two groups had similar LPL mRNA levels, a typical 
mature AT marker [36], indicating that both procedures 
preserved the lipogenic nature of the specimens (Fig. 2a). 
Haematoxylin and eosin (H&E) staining confirmed that 
C-AT retained the typical histological properties of 
human fat, including mature adipocytes, a stromal frac-
tion and blood cells (Fig. 2b and inset). MF-AT not only 
preserved these features but revealed enriched cellular-
ity with a greater extracellular matrix (Fig. 2c and inset). 
The glycosaminoglycan nature of the observed tissues 
was confirmed by the intense Alcian Blue staining of the 
MF-AT samples only, demonstrating the presence of a 
more abundant stromal extracellular matrix after MF 
processing (Fig. 2b, c and insets).
MF‑AT preservation is associated with higher HOXB7 
and bFGF levels
HOXB7 is downregulated in MSC during ageing and 
positively connected with the increased performance 
Fig. 1 Overview of experiment. a AT has been harvested and processed according to Lipogems or Coleman techniques to obtain, respectively, 
MF-AT and C-AT. Specimens were processed for histological assays and qRT-PCR (t = 0, t = 5 days). b MF-AT were incubated with osteoarthritis SF 
and processed at 1 days and 5 days for histological assays and qRT-PCR. c Similarly, MSC-AT were stimulated with SF and analysed by viability assay 
(MTT), histology and qRT-PCR
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of these cells [27, 28]. To investigate the distinct behav-
iour of the differentially processed AT, HOXB7 expres-
sion was evaluated. Significantly higher levels of HOXB7 
were observed in MF-AT compared to C-AT (Fig.  2d, 
upper graph; p = 0.01). Because bFGF is a known tran-
scriptional target of HOXB7 involved in tissue repair 
and regeneration [27, 37], we determined the expression 
of this factor in the MF-AT and C-AT samples. Interest-
ingly, freshly processed MF-AT had greater bFGF expres-
sion compared to C-AT (Fig. 2d, lower graph; p = 0.02), 
indicating that the higher HOXB7 and bFGF levels may 
account for the better MF-AT preservation.
MF‑AT, not C‑AT, retains higher cellularity and abundant 
stroma
Isolated samples were cultured in a maintenance medium 
to assess the long-term persistence of AT structure and 
functionality. After 5  days, progressive deterioration 
of the C-AT structures was observed with a massive 
loss of cellularity in the mature adipocytes and stromal 
compartment (Fig. 2e and inset). Moreover, Alcian Blue 
staining was not detected (Fig. 2e and inset). In contrast, 
5-day-old MF-AT cultures displayed a better-preserved 
adipose cell compartment with enriched cellularity 
(Fig.  2f and inset) and positive Alcian Blue staining of 
the stromal fraction (Fig. 2f and inset). The HOXB7 and 
bFGF expression levels after the 5-day-old cultures did 
not significantly differ between C-AT and MF-AT (data 
not shown). Collectively, these data suggest that MF-AT 
performed better than C-AT overall; however, this find-
ing was not associated with a persistent molecular 
pattern.
Osteoarthritic SF‑stimulated MF‑AT preserved ex vivo 
and is associated with increased proliferation
Based on the known regenerative properties of MF-AT, 
we developed an ex  vivo preclinical model to mimic 
what may take place in the knees of patients affected by 
osteoarthritis after MF-AT transplantation. This model 
was used to verify whether pathologic SF has a detri-
mental impact on MF-AT performance. 1-day and 5-day 
micro-tissue pellet cultures were compared after seeding 
MF-AT (n = 3) in SF from osteoarthritic patients or con-
trol maintenance medium. H&E staining of the 1-day and 
5-day cultures was used to evaluate the biological impact 
























































Fig. 2 Comparison of histological staining and gene expression of MF-AT and C-AT. a, d qRT-PCR analysis of gene expression. LPL (a), HOXB7 
and bFGF (d) mRNA expression levels were measured in freshly isolated MF-AT and C-AT (*p = 0.01 for HOXB7 and *p = 0.02 for bFGF, unpaired 
two-tailed Student’s t-test). Error bars, SEM. (b, c, e, f) H&E and Alcian Blue-Nuclear Fast Red staining of freshly isolated C-AT (b) and MF-AT (c) and 
their respective five-day cultures (e, f). Photomicrographs were acquired using an Axio Imager M2 (Zeiss) with EC Plan APOCHROMAT ×20/0.8 and 
EC Plan Neofluar ×40/0.75 objectives
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the preservation of typical AT architecture containing 
mature adipocytes and an SVF (Fig.  3a–d). Alcian Blue 
staining confirmed the conserved AT glycosaminogly-
can nature of the cultures at both time points and cul-
ture conditions (Fig.  3a–d). There were no substantial 
differences between the SF and control medium cultures. 
The levels of Ki67 (proliferation marker) were analysed 
to evaluate the possible effect of SF on the proliferation 
of the MF-AT ex vivo cultures. A statistically significant 
increase in Ki67 levels was noticed between days 1 and 
5 in culture (p = 0.000001), indicating that the osteo-
arthritic SF was able to maintain MF-AT proliferation 
without the addition of growth supplements (p = 0.7 vs 
control medium, not statistically significant) (Fig. 4a).
In order to assess the impact of SF, we evaluated the 
expression of Cyclin A and Cyclin E as key regulator 
of cell cycle. As shown in Fig.  4b, SF didn’t alter Cyclin 
A and E expression both after 1 day and 5  days of cell 
culture, confirming that SF didn’t impact the cell pro-
liferation. After 5  days of stimulation, we detected an 
important increase in both cyclins’ expression, strongly 
confirming the maintained viability of organ culture. 
These data demonstrated that pathologic SF does not 
affect MF-AT performance ex vivo.
The importance of the impact of SF on cell prolifera-
tion was evaluated also after one day of stimulation in a 
Lipogems-derived MSC. We performed BrdU staining in 
order to detect and to quantify the quote of the cells in S 
phase of cell cycle. SF stimulation showed approximately 
twofold increased fluorescence compared to untreated 
cells, as reported in figure S1.
Preservation of the osteoarthritic SF‑stimulated 
micro‑tissue system is associated with high HOXB7 
and bFGF expression levels
HOXB7 expression was analysed by immunohis-
tochemistry (IHC) and quantitative real time-PCR 
(qRT-PCR) to assess the role of SF in preserving the 
performance of MF-AT. As shown in Fig.  5a, HOXB7 























































Fig. 3 H&E and Alcian Blue staining of MF-AT treated with SF. H&E and Alcian Blue-Nuclear Fast Red staining of MF-AT following treatment with SF 
or maintenance medium for 1 (a, b) or 5 (c, d) days. Photomicrographs were acquired using an Axio Imager M2 (Zeiss) with EC Plan APOCHROMAT 
×20/0.8 and EC Plan Neofluar ×40/0.75 objectives
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increased at day 5 after SF stimulation (Fig. 5a). In con-
trast, HOXB7 mRNA expression decreased from days 
1 to 5 (p = 0.0003). SF stimulation further decreased 
HOXB7 mRNA levels compared to the control medium 
(p = 0.04) (Fig.  5b). The mRNA levels of the HOXB7 
target bFGF were also evaluated to analyse the down-
stream effects of HOXB7 on MF-AT. The bFGF mRNA 
levels significantly decreased (time p = 0.000005) from 
days 1 to 5 in culture. Stimulation with SF increased 
bFGF mRNA levels at both time points (p = 0.03), con-
firming a role for SF in promoting tissue repair and 
regeneration (Fig. 5c).
These data suggested that HOXB7 and bFGF 
induced by osteoarthritic SF might account for MF-AT 
preservation.
We performed In-Cell western in order to quantify the 
intracellular relative protein levels of HOXB7 and bFGF.
In this system, SF stimulation decreases the levels of 
HOXB7 protein at 1 and 5 days of treatment (Fig. S2A). 
bFGF protein decreased after 5  days of culture. Indeed, 
at 1 day, SF stimulation, not significantly impact on bFGF 
expression (Fig. S2B).
Synovial fluid alters AT‑MSC morphology, HOXB7 
expression and metabolic activity
To better define the effect of SF on AT-derived cells, we 
developed 2D and 3D pellet culture in  vitro models of 
isolated AT-MSC treated for 24 h with SF from patients 
with osteoarthritis or control maintenance medium. 
H&E staining of the 3D AT-MSC pellet treated with SF 
revealed increased cellularity and a higher amount of 
extracellular matrix compared to the control (Fig.  6a). 
Interestingly, AT-MSC treated with SF contained a mix 
of spindle and round-shaped cells with a large cytoplasm 
resembling chondrocytes (arrows in Fig. 6a inset). MTT 
and Neutral Red metabolic assays were performed on 
2D cultures to further compare SF and the maintenance 
medium. Both assays showed a statistically significant 
increase in AT-MSC viability after SF stimulation com-
pared to the control medium (MTT p = 0.01; Neutral Red 
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p < 0.009 p > 0.05
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Fig. 4 Ki67 expression in MF-AT treated with SF. qRT-PCR analysis of Ki67 mRNA expression levels in MF-AT evaluated at 1 or 5 days after treatment 
with SF or maintenance medium (*p = 0.000001, two-way ANOVA). Error bars, SEM
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p = 0.01) (Fig.  6b, c). Collectively, these data indicated 
how SF could modify AT-MSC morphology and viability.
HOXB7 and bFGF expression were also analysed to 
determine the effect of SF on the performance of 3D AT-
MSC cultures. HOXB7 and bFGF mRNA levels decreased 
after treatment with SF for 24  h (p = 0.002 vs control; 
Fig.  7a, b). However, HOXB7 protein levels increased 
after the 24  h SF treatment (Fig.  7c). Collectively, these 
data indicated that SF influenced isolated AT-MSC per-
formance by modulating HOXB7/bFGF pathways.
Discussion
The use of AT as a source of MSC for regenerative medi-
cine applications (e.g., skeletal disorders) is a rapidly 
growing area of research. The current study clarified 
some aspects of AT behaviour ex vivo and demonstrated 
that better preserved AT features are obtained using 
microfragmentation rather than centrifugation during 
ex  vivo manipulation. A positive outcome in osteoar-
thritis treatment has been reported [10, 11, 38] MF-AT 
had surprisingly higher HOXB7 and bFGF expression in 
a pathologic SF environment, suggesting that these fea-
tures are possible players in the beneficial impact on joint 
homeostasis. To investigate which AT processing method 
better preserves AT histology and performance and pro-
motes regenerative mechanisms, two different meth-
ods (MF vs. C) were compared. The MF-AT cultures in 
a maintenance medium were well preserved with higher 
cellularity and stromal extracellular matrix compared to 
C-AT. The increase in the cellular and stromal compart-
ments, rich in Glycosaminoglycan, in MF-AT compared 
to C-AT was consistent with the findings of Bosetti et al. 
[26] on chondrogenic organ cultures from lipoaspirates.
In our study, the better performance of MF-AT was 
originally investigated by analysing HOXB7 and bFGF 
expression. Indeed, it is known that HOXB7 is down-
regulated by high levels of miR196 in aged MSC, thus 
regulating ageing rather than proliferation, skeleton for-
mation and homeostasis in the post-natal skeleton [27]. 
The enhanced HOXB7 mRNA levels of freshly isolated 
MF-AT could play an important role in the mechanisms 
underlying the clinical success of MF-AT through spe-
cific molecular pathways. Increased HOXB7 expression 
in human AT was previously observed in human abdomi-
nal subcutaneous AT depots compared to gluteal depots 
[39]. However, its expression in differentially processed 
AT was not previously reported. bFGF mRNA levels also 
increased in the freshly prepared MF-AT. It is known that 
TIME TREATMENT
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Fig. 5 HOXB7 and bFGF expression in MF-AT treated with SF. a HOXB7 protein expression in MF-AT by IHC. Analysis was performed 1 or 5 days after 
treatment with SF or maintenance medium. Photomicrographs were acquired using an Axio Imager M2 (Zeiss) with an EC Plan Neofluar ×40/0.75 
objective. b, c qRT-PCR analysis of HOXB7 (b) and bFGF (c) mRNA expression levels in MF-AT 1 or 5 days after treatment with SF or maintenance 
medium (*time p = 0.0003 and treatment p = 0.04 for HOXB7; *time p = 0.000005 and treatment p = 0.03 for bFGF; two-way ANOVA). Error bars, SEM
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bFGF indirectly promotes wound healing and immune 
and inflammatory responses, thus triggering endog-
enous regenerative mechanisms against tissue damage 
[30]. Therefore, the MF-AT regenerative potential may 
be linked to the activation of HOX pathways by mechani-
cal stimuli that can upregulate anti-inflammatory genes 
and, in parallel, downregulate TNF-α in lipoaspirates 
[40]. In addition, it has been reported that mechanically 
stimulated MSC express chondrogenic genes [41]. Thus, 
it may be that mechanical stimulation is crucial for the 
enhanced expression of HOX genes and should be fur-
ther investigated.
We developed an ex vivo model that mimics the osteo-
arthritic setting after MF-AT transplant. SF is a key com-
ponent of the knee microenvironment that promotes 
cartilage lubrification and reduces attrition. Significant 
changes occur during osteoarthritis because of direct 
alterations in SF and indirect changes in the surrounding 
synovial tissues [35]. To understand how the pathologic 
changes in SF can influence AT survival, we used SF as 
a culture medium. The organotypic AT cultures devel-
oped by Bosetti et al. [26] and rat AT fragments incorpo-
rated in collagen type I described by Toda et al. [42] have 
been used to study AT regenerative mechanisms [26, 
42]. However, to our knowledge, an organotypic MF-AT 
culture using SF alone has not been previously generated. 
This relatively simple approach can preserve MF-AT 
architecture for up to 5  days in culture, even without 
additional growth factors. Thus, this approach overcomes 
the current limitations of organotypic cultures that have 
never survived more than 48  h [43], allowing a longer 
observation time for deeper investigation.
In this model, basic cell features were evaluated, such 
as the proliferation marker Ki67, and cell cycle regulators 
Cyclin A and Cyclin E [44–46]. Ki67 was expressed at low 
levels at day 1, possibly due to the quiescent state of cells 
during the early phases of culture. Increased Ki-67 was 
observed after 5 days in culture, confirming that the short 
half-life of cultured tissue can be overcome. Similarly, 
expression of Cyclin A and Cyclin E confirm this trend. 
Furthermore, HOXB7 was expressed in the MF-AT at 
all time points with or without SF stimulation. The high 
proliferation rate of MF-AT at 5 days might be related to 
the high HOXB7 expression, as shown by our group for 
tissue-isolated MSC [27, 28].
In this study, we observed an inverse relationship 
between HOXB7 mRNA and protein expression that 
requires further investigation. These results may be 
explained by negative feedback mechanisms on HOXB7 
transcription that are triggered by high HOXB7 protein 






Fig. 6 H&E staining and proliferative rate of 3D AT-MSC cultures after SF treatment. a H&E staining of 3D AT-MSC cultures 1 day after treatment with 
SF or maintenance medium. Photomicrographs were acquired using an Axio Imager M2 (Zeiss) with an EC Plan APOCHROMAT ×20/0.8 objective. 
Arrows (inset): large cytoplasmic cells resembling chondrocytes. b, c Proliferative rates of 2D AT-MSC cultures determined by MTT (b) and Neutral 
Red (c) assays 1 day after treatment with SF or maintenance medium (*p = 0.01 for both assays, unpaired two-tailed Student’s t-test). Error bars, SD
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levels. Such mechanisms have been described for other 
transcription factors controlling stem cell pluripotency 
and self-renewal [47]. Therefore, we hypothesize that a 
mechanism similar to that previously described for Oct4, 
Nanog and FoxD3 [47] may be necessary to maintain a 
proper balance of HOXB7 expression levels.
The increased HOXB7 described in this study may, 
in part, explain the enhanced cellularity and stromal 
compartment in MF-AT compared to C-AT. Because 
HOXB7 effects can be mediated by bFGF, an impor-
tant HOXB7 transcriptional target [27, 37] expressed 
by human pericytes [48] and adipocytes [49], its mRNA 
levels were investigated in MF-AT following SF treat-
ment. SF increased bFGF mRNA levels in 1-day and 
5-day cultures, suggesting that SF promotes the activa-
tion of regenerative mechanisms. The trends of HOXB7 
and bFGF mRNA expression in MF-AT cultured with 
SF were opposite each other, suggesting that bFGF lev-
els might be upregulated not only by HOXB7 but also 
by cytokines contained in the SF. Our ex vivo model has 
highlighted the different biological aspects of MF-AT 
for regenerative approaches; however, the precise role 
of SF in the preservation of AT in knee osteoarthritis 
has not been completely defined due to the limitations 
of organotypic ex  vivo cultures and the complexity of 
the pathology.
Because of these limitations, we also developed a sim-
plified in  vitro model to evaluate the impact of SF on 
isolated AT-MSC. This model showed that, after one day 
of treatment with osteoarthritic SF, the AT-MSC prolif-
eration rate significantly increased compared to control 
conditions, and their morphology became similar to 
chondroblasts. Indeed, treatment of 3D cultures of horse 
BM-MSC with autologous SF in culture medium for 
26  days induces high expression of both proteoglycans 
and type II collagen, indicating that SF promotes chon-
drogenic differentiation of MSC and supporting their use 
to treat cartilage defects [50]. In our model, there was no 
effective chondrogenic differentiation of AT-MSC after 
treatment with SF, which might indicate that the time 
points of our analysis were too early; however, the modi-
fied morphology suggested an initial propensity for this 
commitment. Moreover, AT-MSC treated by SF in the 
absence of culture medium cannot be cultured for a long 
time, which is required for standard chondrogenic differ-
entiation assays [28].
Fig. 7 HOXB7 and bFGF expression in 3D AT-MSC cultures treated with SF. a, b qRT-PCR analysis of HOXB7 (a) and bFGF (b) mRNA expression levels 
in 3D AT-MSC cultures 1 day after treatment with SF or maintenance medium (*p = 0.002 for HOXB7, unpaired two-tailed Student’s t test). Error bars, 
SD. (c) HOXB7 protein expression in 3D AT-MSC cultures by IHC. Analysis was performed 1 day after treatment with SF or maintenance medium. 
Photomicrographs were acquired using an Axio Imager M2 (Zeiss) with an EC Plan Neofluar ×40/0.75 objective
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SF significantly enhanced HOXB7 expression by IHC, 
suggesting that SF may help to prevent MSC ageing and 
preserve their regenerative potential. A previous study of 
HOXB7 expression in MSC suggested that, in vitro, the 
upregulation of this gene in AT-MSC increased the cell 
proliferation rate, decreased senescence and improved 
osteogenesis, resulting in MSC cellular reprogramming 
[27]. This finding is consistent with our observations 
in the in  vitro model, where high HOXB7 levels likely 
accounted for the increased AT-MSC proliferation rate 
after SF stimulation. To investigate the downstream effect 
of HOXB7 following SF treatment, we examined bFGF 
mRNA levels and found a decreasing trend that did not 
reach statistical significance. Thus, SF did not affect the 
transcription of this gene in AT-MSC, suggesting that the 
increase in bFGF levels observed after SF treatment in 
the ex vivo model may be related to a combination of tis-
sue microfragmentation and SF treatment and not to the 
SF effects on AT-MSC alone.
While several aspects of the regenerative potential of 
MF-AT need to be clarified, our study suggests that the 
mechanical procedure, MF, used to obtain adipose speci-
mens preserves MF-AT histology in association with 
HOXB7 gene expression and trophic factors capable of 
preserving AT itself and, potentially, contributing to tis-
sue repair. A better understanding of MF-AT biology is a 
pre-requisite to a better understanding of the substantial 
benefit of MF-AT transplantation in patients [51]. Our 
study presents a novel procedure that could potentially 
enhance the therapeutic profile of AT to achieve a more 
favourable prognosis.
Conclusion
In conclusion, our study better clarifies the biology of 
MF-AT showing the expression of trophic factors such 
as bFGF improving the tissue viability. Cell model with 
MF-AT and SF confirms that inflammatory microenvi-
ronment didn’t decrease expression of those trophic fac-
tors. Our finding may highlight the potential benefit of 
MF-AT treatment of inflammatory diseases achieving a 
more favourable prognosis.
Materials and methods
The main idea of the manuscript is summarized in Fig. 1.
Patients
Lipoaspirates used to compare C-AT and MF-AT pro-
cessing were performed from the abdominal site of 
patients (n = 10) referred to Department of Medical and 
Surgical Sciences for Children & Adults, University of 
Modena and Reggio Emilia. Lipoaspirates used to evalu-
ate SF impact on MF-AT and AT-MSC were obtained 
from the abdomens of patients (n = 3) affected by knee 
osteoarthritis referred to the Departments of Orthopae-
dic Surgery and Plastic, Reconstructive and Aesthetic 
Surgery, University of Modena and Reggio Emilia. SF 
were harvested from the knees of patients (n = 8) affected 
by osteoarthritis referred to the Department of Ortho-
paedic Surgery, University of Modena and Reggio Emilia. 
AT-MSC were isolated from lipoaspirates of patients 
(n = 2) who underwent plastic breast reconstructive 
surgery following mastectomy. All procedures were per-
formed with informed consent and approval by the Local 
Ethics Committee n. 254. The specimens were tested for 
the presence of HIV (1 and 2), hepatitis C virus, hepati-
tis B virus and cytomegalovirus, and all specimens were 
negative for all these pathogens.
AT harvesting and processing
The surgical procedure for AT harvesting was performed 
under local anaesthesia and sedation. After the skin inci-
sion, the donor abdominal area was infiltrated using a 
blunt cannula filled with anaesthetic solution (100  mL 
saline, 10 mL 7.5 mg/mL levobupivacaine, 20 mL 10 mg/
mL mepivacaine and 0.5 mL 1 mg/mL epinephrine). AT 
was harvested through the same incision with a blunt 
cannula. The cannula used for sampling was connected to 
a syringe that was progressively filled. The mean volume 
of lipoaspirate collected from each patient was 60  mL. 
MF was performed according to the method of Randelli 
et al. [52] on 30 mL lipoaspirate using a Lipogems device 
and yielded 10  mL MF-AT. The remaining lipoaspirate 
(30 mL) was processed by centrifugation using the Cole-
man technique [4]. The lipoaspirate was centrifuged at 
3000 rpm for 3 min, resulting in three distinct layers: top 
layer, oil derived from fat cells; intermediate layer, adi-
pocytes and SVF; bottom layer, blood cells, water and 
anaesthetic mixture. The intermediate layer (C-AT) was 
collected for subsequent experiments [4, 53].
MF-AT and C-AT were cultured in maintenance 
medium, consisting of Minimum Essential Medium 
(α-MEM) without nucleosides (Gibco Life Technology), 
2.5% Platelet lysate, 2 mM L-glutamine, 100 U/mL peni-
cillin, 100 μg/mL streptomycin (all from Gibco Life Tech-
nology) and 0.2% heparin (Sigma-Aldrich), for 5 days at 
37 °C and 5%  CO2. The ex vivo model was generated by 
adding SF in the absence of culture medium to MF-AT 
for 1 or 5 days at 37 °C and 5%  CO2. MF-AT cultured in 
maintenance medium were used as a negative control.
AT‑MSC culture and metabolic assays
AT-MSC were isolated from AT as previously described 
[54] and cultured at a density of 6000 cells/cm2 in main-
tenance medium at 37 °C and 5%  CO2. Subsequently, AT-
MSC were cultured in SF alone or maintenance medium 
for 1  day at 37  °C and 5%  CO2. MTT and Neutral Red 
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metabolic assays were performed as previously reported 
(UNI EN ISO 10993-5:2009). The in vitro model (pellet) 
was generated by culturing 3 ×  105 AT-MSC in mainte-
nance medium in conical polypropylene centrifuge tubes 
(EuroClone) at 37 °C and 5%  CO2. After 1 day of culture, 
the in vitro models were stimulated with SF, or mainte-
nance medium as negative control, and cultured for an 
additional day.
Histology and immunohistochemical analysis
Histology and immunohistochemical analysis were 
performed on MF-AT, C-AT and the in  vitro models. 
Four-μm sections were obtained from formalin-fixed, 
paraffin-embedded samples. Histological analysis was 
performed using H&E (Sigma-Aldrich) and Alcian Blue-
Nuclear Fast Red (Sigma-Aldrich) staining. IHC was 
performed as previously described [21]. Paraffin sec-
tions were stained with rabbit anti-human HOXB7 (1:40; 
Abnova), rabbit anti-human cyclin A (1:75; Santa Cruz) 
and rabbit anti-human Cyclin E (1:75; Santa Cruz). Stain-
ing was analysed using the Axio Imager M2 (Zeiss; EC 
Plan APOCHROMAT 20×/0.8 and EC Plan Neofluar 
40×/0.75 objectives) and ZenPro software (Zeiss).
qRT‑PCR
Total RNA from MF-AT, C-AT and 3D AT-MSC cultures 
was harvested using TRIzol reagent, according to the 
manufacturer’s instructions (Invitrogen). cDNAs were 
generated with random hexamers using the RevertAid 
First Strand cDNA Synthesis Kit (Fermentas, Thermo 
Fisher Scientific). RNA and cDNA were quantified with 
a Beckman Coulter spectrophotometer. qRT-PCR was 
performed using Fast SYBR Green Master Mix (Applied 
Biosystems, Thermo Fisher Scientific) with the StepOne 
Real-Time PCR System (Applied Biosystems, Thermo 
Fisher Scientific). The PCR primers are listed in Table 1. 
β-actin was used for normalization. Measurements were 
performed in triplicate. Relative expression was deter-
mined using the ΔΔCt method [55].
Statistics
Data are presented as the mean ± SEM, except for the 
study of SF impact on AT-MSC in which data are pre-
sented as the mean ± SD. Comparisons of two groups 
were made with the two-tailed t-test using Microsoft 
Excel 2010. The study of SF impact on AT was analysed 
using two-way ANOVA (GraphPad Prism 7.04 software). 
Statistical significance was indicated by p < 0.05.
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